COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,757 Articles (22,502 medRxiv, 8,255 bioRxiv)

Most recent first Previous |  Page 524: Articles 5231-5240  | Next

Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting
Chemaitelly, H., Ayoub, H., Tang, P., Coyle, P., YASSINE, H. M., Althani, A., Al-Khatib, H. A., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M., Al-Khal, A., Bertollini, R., Faust, J. S., Abu-Raddad, L. J.
10.1101/2022.11.14.22282103 — Posted: 2022-11-15
Risk of SARS-CoV-2 reinfection is time- and variant-dependant, France, January 2021 to August 2022
Auvigne, V., Schaeffer, J., Boudon, T., Tamandjou, C., Figoni, J., Parent du Chatelet, I., Bernard-Stoecklin, S.
10.1101/2022.11.09.22282113 — Posted: 2022-11-15
COVID-19 IN BRAZIL: A CROSS-SECTIONAL IMMUNO-EPIDEMICAL AND GENOMIC EVALUATION IN A PRE-OMICRON ERA
Rodrigues, S. d. O., Ferrari de Oliveira, G., Costa e Silva, M., Pagnossa, J. P.
10.1101/2022.11.12.22282248 — Posted: 2022-11-15
Protection conferred by Delta and BA.1/BA.2 infection against BA.4/BA.5 infection and hospitalization: A Retrospective Cohort Study
Winchester, N., Shrestha, N., Kim, P., Tereshchenko, L. G., Rothberg, M.
10.1101/2022.11.14.22282310 — Posted: 2022-11-14
Risk factors and symptom clusters for Long Covid: analysis of United Kingdom symptom tracker app data.
Ford, E., Parfitt, H., McCheyne, I., Kiss, I., Sellers, R.
10.1101/2022.11.14.22282285 — Posted: 2022-11-14
Multi-omic spatial profiling reveals the unique virus-driven immune landscape of COVID-19 placentitis
Pugh, M., Fennel, E., Leahy, C. I., Perry, T., Hargitai, B., Marton, T., Hunter, K. J., Halford, G., Yilmaz, H. O., Stamataki, Z., Reynolds, G., Hill, H. J., Willcox, B. E., Steven, N. M., Thornton, C. A., Dojcinov, S., Culhane, A., Murray, P. G., Taylor, G. S.
10.1101/2022.11.14.516398 — Posted: 2022-11-14
Genetic and structural data on the SARS-CoV-2 Omicron BQ.1 variant reveal its low potential for epidemiological expansion
Scarpa, F., Sanna, D., Benvenuto, D., Borsetti, A., Azzena, I., Casu, M., Fiori, P. L., Giovanetti, M., Maruotti, A., Ceccarelli, G., Caruso, A., Caccuri, F., Cauda, R., Cassone, A., Pascarella, S., Ciccozzi, M.
10.1101/2022.11.11.516052 — Posted: 2022-11-14
SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta): Monitoring and efficacy
Oh, D. Q. P., Grothe, I., Lukass, H., Kreiter, A. K., Hoffmann, M., Wegener, D.
10.1101/2022.11.11.516206 — Posted: 2022-11-14
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
Radic, L., Sliepen, K., Yin, V., Brinkkemper, M., Capella-Pujol, J., Schriek, A. I., Torres, J. L., Bangaru, S., Burger, J. A., Poniman, M., Bontjer, I., Bouhuijs, J. H., Gideonse, D., Eggink, D., Ward, A. B., Heck, A. J. R., van Gils, M. J., Sanders, R. W., Schinkel, J.
10.1101/2022.11.11.516125 — Posted: 2022-11-14
Immune response of primary and booster immunity of SARS-CoV-2 vaccination among patients with chronic liver disease: a real-world study
Song, R., Yang, C., wang, J., Li, Q., chen, J., sun, K., Lv, H., Yang, Y., Liang, J., Ye, Q., Gao, Y., Li, J., Li, Y., Yan, J., Liu, Y., Wang, T., Liu, C., Wang, F., Yin, W., Xiang, h.
10.1101/2022.11.12.22282242 — Posted: 2022-11-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).